We are live on ! Find out more
TCWM

Total Clarity Wealth Management Portfolio holdings

AUM $515M
1-Year Est. Return 27.37%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+27.37%
3 Year Est. Return
+69.7%
5 Year Est. Return
+74.47%
10 Year Est. Return
–
AUM
$133M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow %
96.49%
Top 10 Hldgs %
29.58%
Holding
692
New
691
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
FTCS icon
First Trust Capital Strength ETF
FTCS
+$5.72M
2
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$5.32M
3
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$4.98M
4
LGLV icon
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
+$4.46M
5
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$3.56M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 8.28%
2 Healthcare 7.89%
3 Financials 5.8%
4 Consumer Discretionary 3.75%
5 Industrials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
676
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1K ﹤0.01%
+125
New +$1.15K
TAK icon
677
Takeda Pharmaceutical
TAK
$55.9B
$1K ﹤0.01%
+45
New +$861
VMBS icon
678
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$1K ﹤0.01%
+10
New +$532
ABMD
679
DELISTED
Abiomed Inc
ABMD
$1K ﹤0.01%
+6
New +$1.11K
TYME
680
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$1K ﹤0.01%
+900
New +$1.09K
ACAD icon
681
Acadia Pharmaceuticals
ACAD
$5.01B
$0 ﹤0.01%
+10
New +$435
ASIX icon
682
AdvanSix
ASIX
$428M
$0 ﹤0.01%
+1
New +$22
ATNM icon
683
Actinium Pharmaceuticals
ATNM
$24.3M
$0 ﹤0.01%
+20
New +$138
AVNW icon
684
Aviat Networks
AVNW
$272M
$0 ﹤0.01%
+2
New +$14
CLDX icon
685
Celldex Therapeutics
CLDX
$3.27B
$0 ﹤0.01%
+8
New +$19
GTX icon
686
Garrett Motion
GTX
$5.51B
$0 ﹤0.01%
+43
New +$438
HST icon
687
Host Hotels & Resorts
HST
$15.5B
$0 ﹤0.01%
+6
New +$104
TCRT icon
688
Alaunos Therapeutics
TCRT
$4.79M
– –
0
– –
USHY icon
689
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.1B
$0 ﹤0.01%
+5
New +$204
WAB icon
690
Wabtec
WAB
$49.2B
$0 ﹤0.01%
+2
New +$148
BMY.RT
691
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$0 ﹤0.01%
+53
New +$138
FTR
692
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
+15
New +$12
24 25 26 27
28

Similar funds

PDIP
Palo Duro Investment Partners Chicago, Illinois $515M AUM 36.69% 1-Year Est. Return
VPP
Vertex Planning Partners Downers Grove, Illinois $515M AUM 14.66% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
AGC
Aspen Grove Capital Avon, Colorado $514M AUM 21.8% 1-Year Est. Return
SC
Schoolcraft Capital Boulder, Colorado $516M AUM 16.37% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
LHC
Lodge Hill Capital New York $518M AUM 12.89% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $511M AUM 18.81% 1-Year Est. Return

Total Clarity Wealth Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Total Clarity Wealth Management, which disclosed 692 positions worth $133M. Its ten largest holdings account for 30% of the portfolio.

Its largest position is First Trust Capital Strength ETF: 98,271 shares worth $5.93M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, followed by Healthcare and Financials.

  • Total Clarity Wealth Management's largest Q4 2019 buy was First Trust Capital Strength ETF: 98,271 shares worth $5.93M.
  • Total Clarity Wealth Management's ten largest holdings make up 30% of its $133M portfolio in Q4 2019.
  • Total Clarity Wealth Management disclosed 692 positions in Q4 2019, its first 13F filing on record.

Based on Total Clarity Wealth Management's 13F filing for Q4 2019, filed 27 Feb 2020.